Ventilator-associated pneumonia and atelectasis: evaluation through bronchoalveolar lavage fluid analysis

2003 ◽  
Vol 29 (4) ◽  
pp. 555-563 ◽  
Author(s):  
G. Nakos ◽  
H. Tsangaris ◽  
S. Liokatis ◽  
E. Kitsiouli ◽  
M. E. Lekka
Keyword(s):  
Bronchoalveolar Lavage ◽  
Bronchoalveolar Lavage Fluid ◽  
Lavage Fluid ◽  
Ventilator Associated Pneumonia ◽  
Fluid Analysis

scholarly journals Endotracheal Aspirate and Bronchoalveolar Lavage Fluid Analysis: Interchangeable Diagnostic Modalities in Suspected Ventilator-Associated Pneumonia?

2014 ◽  
Vol 52 (10) ◽  
pp. 3597-3604 ◽  
Author(s):  
J. B. J. Scholte ◽  
H. A. van Dessel ◽  
C. F. M. Linssen ◽  
D. C. J. J. Bergmans ◽  
P. H. M. Savelkoul ◽  
...  
Keyword(s):  
Bronchoalveolar Lavage ◽  
Bronchoalveolar Lavage Fluid ◽  
Lavage Fluid ◽  
Ventilator Associated Pneumonia ◽  
Endotracheal Aspirate ◽  
Fluid Analysis ◽  
Diagnostic Modalities

Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C

2001 ◽  
Vol 66 (1) ◽  
pp. 34-39 ◽  
Author(s):  
Ramazan Idilman ◽  
Hülya Çetinkaya ◽  
İsmail Savaş ◽  
Nuray Aslan ◽  
Serpil Dizbay Sak ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Bronchoalveolar Lavage ◽  
Chronic Hepatitis C ◽  
Bronchoalveolar Lavage Fluid ◽  
Lavage Fluid ◽  
Fluid Analysis

scholarly journals Azithromycin Attenuates Lung Inflammation in a Mouse Model of Ventilator-Associated Pneumonia by Multidrug-Resistant Acinetobacter baumannii

2013 ◽  
Vol 57 (8) ◽  
pp. 3883-3888 ◽  
Author(s):  
Koichi Yamada ◽  
Katsunori Yanagihara ◽  
Norihito Kaku ◽  
Yosuke Harada ◽  
Yohei Migiyama ◽  
...  
Keyword(s):  
Mouse Model ◽  
Bronchoalveolar Lavage ◽  
Acinetobacter Baumannii ◽  
Lung Inflammation ◽  
Bronchoalveolar Lavage Fluid ◽  
Lavage Fluid ◽  
Multidrug Resistant ◽  
Control Group ◽  
Ventilator Associated Pneumonia ◽  
Content Type

ABSTRACTAcinetobacter baumanniiis one of the main pathogens that cause ventilator-associated pneumonia (VAP) and is associated with a high rate of mortality. Little is known about the efficacy of macrolides againstA. baumannii. In order to confirm the efficacy of azithromycin (AZM) against VAP caused by multidrug-resistantA. baumannii(MDRAB), we used a mouse model that mimics VAP by placement of a plastic tube in the bronchus. AZM (10 and 100 mg/kg of body weight) was administered subcutaneously every 24 h beginning at 3 h after inoculation. Phosphate-buffered saline was administered as the control. Survival was evaluated over 7 days. At 48 h postinfection, mice were sacrificed and the numbers of viable bacteria in lungs and bronchoalveolar lavage fluid were compared. Histopathological analysis of lung specimens was also performed. The treatment groups displayed significantly longer survival than the control group (P< 0.05). AZM did not have an antimicrobial effect. Histopathological examination of lung specimens indicated that the progression of lung inflammation was prevented in the AZM-treated groups. Furthermore, total cell and neutrophil counts, as well as cytokine levels, in bronchoalveolar lavage fluid were significantly decreased (P< 0.05) in the AZM-treated groups. AZM may have a role for the treatment of VAP with MDRAB because of its anti-inflammatory effects.

scholarly journals Correlation between the Diagnostic Yield from the Bronchoalveolar Lavage Fluid Analysis and Clinicoradiological Findings in Sarcoidosis

2020 ◽  
Vol 21 (1) ◽  
pp. 21-26 ◽  
Author(s):  
Fatma Tokgoz Akyil ◽  
◽  
Meltem Agca ◽  
Hatice Ozturk ◽  
Esin Sonkaya ◽  
...  
Keyword(s):  
Bronchoalveolar Lavage ◽  
Bronchoalveolar Lavage Fluid ◽  
Diagnostic Yield ◽  
Lavage Fluid ◽  
Fluid Analysis
Sign in / Sign up

Export Citation Format

Share Document